- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CHINA BIOTECH SERVICES Aktie jetzt für 0€ handeln | |||||
| 03.09. | CH BIOTECH SER (08037): VOLUNTARY ANNOUNCEMENT - COOPERATION AGREEMENT IN RELATION TO CROSS-BORDER BNCT CLINICAL SERVICES | 2 | HKEx | ||
| 28.08. | CH BIOTECH SER (08037): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026 | - | HKEx | ||
| 13.08. | CH BIOTECH SER (08037): COMPLETION OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE ... | - | HKEx | ||
| 12.08. | CH BIOTECH SER (08037): NOTICE OF BOARD MEETING | - | HKEx | ||
| 12.08. | CH BIOTECH SER (08037): POSITIVE PROFIT ALERT | - | HKEx | ||
| 12.08. | CH BIOTECH SER (08037): VOLUNTARY ANNOUNCEMENT - MASTER COLLABORATION AGREEMENT WITH STELLA PHARMA CORPORATION IN RELATION TO COMMERCIALISATION OF BNCT ... | 1 | HKEx | ||
| 07.08. | CH BIOTECH SER (08037): COMPLETION OF DISCLOSEABLE TRANSACTION INVESTMENT IN A SUBSIDIARY OF THE COMPANY BY AN INVESTOR | 2 | HKEx | ||
| 03.08. | CH BIOTECH SER (08037): COMPANY INFORMATION SHEET | - | HKEx | ||
| 03.08. | CH BIOTECH SER (08037): VOLUNTARY ANNOUNCEMENT - PRESENTATION OF INITIAL FOLLOW-UP FINDINGS OF BORON NEUTRON CAPTURE THERAPY AT THE 22ND CONGRESS ON NEUTRON ... | 2 | HKEx | ||
| 30.06. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 30.06. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx | ||
| 30.06. | CH BIOTECH SER (08037): MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND ... | 1 | HKEx | ||
| 30.06. | CH BIOTECH SER (08037): GRANT OF WAIVER UNDER RULE 19.41(A) OF THE GEM LISTING RULES AND FURTHER DELAY IN DESPATCH OF THE CIRCULAR IN RESPECT OF MAJOR ... | - | HKEx | ||
| 26.06. | CH BIOTECH SER (08037): FURTHER DELAY IN DESPATCH OF THE CIRCULAR IN RESPECT OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE ... | - | HKEx | ||
| 26.06. | CH BIOTECH SER (08037): UPDATES ON DISCLOSEABLE TRANSACTION INVESTMENT IN A SUBSIDIARY OF THE COMPANY BY AN INVESTOR | - | HKEx | ||
| 16.06. | CH BIOTECH SER (08037): SUPPLEMENTAL ANNOUNCEMENT TO THE UPDATE ON EXEMPTED CONNECTED TRANSACTION IN RELATION TO THE ADOPTION OF SHARE AWARD SCHEME BY ... | - | HKEx | ||
| 15.06. | CH BIOTECH SER (08037): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 15 JUNE 2026 | - | HKEx | ||
| 09.06. | CH BIOTECH SER (08037): GRANT OF WAIVER UNDER RULE 19.41(A) OF THE GEM LISTING RULES AND DELAY IN DESPATCH OF THE CIRCULAR IN RESPECT OF MAJOR TRANSACTION ... | - | HKEx | ||
| 02.06. | CH BIOTECH SER (08037): SUPPLEMENTAL ANNOUNCEMENT - MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC ... | 1 | HKEx | ||
| 22.05. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS | 1 | HKEx |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DEXCOM | 72,80 | 0,00 % | DEXCOM INC - 8-K, Current Report | ||
| MCKESSON | 760,20 | +0,13 % | ShinyHunters expose 6.4M in attack on medical supplier McKesson | ||
| MORE LIFE COMPANY | 0,027 | -0,36 % | XFRA NEW INSTRUMENTS AVAILABLE ON 24.08.2026 | The following instruments on XETRA do have their first trading 24.08.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 24.08.2026
Aktien
1 CA0966311064 Boardwalk Real Estate... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,88 | 0,00 % | BrightSpring auf Wells Fargo Konferenz: Wachstum beschleunigt sich auf breiter Front | ||
| TENON MEDICAL | 5,340 | +0,75 % | Morning Market Movers: Tenon Medical, Shoe Station, Cooper Companies, Culp, Inc. See Big Swings | TOKYO (dpa-AFX) - At 8:20 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 12,760 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| AVEANNA HEALTHCARE | 13,860 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 20,370 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| ADAPTHEALTH | 5,850 | 0,00 % | Truist reiterates Buy on AdaptHealth stock after CFO change | ||
| PROGYNY | 27,080 | 0,00 % | Progyny auf Gesundheitskonferenz von Wells Fargo: Wachstumsperspektiven bleiben intakt | ||
| HEARTFLOW | 45,470 | -0,04 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| FRESENIUS | 45,420 | +1,60 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Fresenius mit einem Kursziel von 56 Euro auf "Buy" belassen. Analyst Graham Doyle hält die Sorgen um das US-Geschäft mit... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,000 | 0,00 % | LifeStance prices 22.3 million share secondary offering at $12.35 | ||
| PROCEPT BIOROBOTICS | 20,070 | 0,00 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| BILLIONTOONE | 98,67 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen |
CHINA BIOTECH SERVICES HOLDINGS LTD gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHINA BIOTECH SERVICES HOLDINGS LTD finden Sie auf Wallstreet Online.